Ozempic and Wegovy may be doing more than helping users drop pounds. A new study from the University of California, San Diego, has found a strong link between GLP-1 medications […] The post Ozempic ...

A real-world analysis of nearly 7000 patients shows GLP-1s are associated with sharply lower death rates at 5 years in ...

Don’t wait for the first symptom. Start regular colorectal cancer screening at 45 years old to stay proactive about your ...

Over 140 medications disrupt the gut microbiome by forcing bacteria into intense nutrient competition, creating an imbalance ...

This study of older, long-term cancer survivors found that chemotherapy was not a driver of late cardiovascular disease (CVD) events. Among the survivors -- which included breast, prostate, colon, and ...

A man in his seventies developed fulminant capecitabine toxicity despite normal DPYD screening, revealing a rare variant that ...

Immunotherapy—could that be an option for me, doctor?” is a question frequently asked by patients with colorectal cancer. The ...

One twin got colon cancer at 21. The other didn't. Their story illustrates the mysterious nature of the rise of colon cancer in young adults.

The actor said that "it's clear that the time is now" to part ways with his "treasures" due to "all of the recent unexpected ...

Irreversible nerve damage to the lower limbs is a common side effect of chemotherapy, yet up to 50% of patients are missing ...

The U.S. Food and Drug Administration has granted Fast Track Designation to a new drug combination for metastatic colorectal ...

NEW YORK – The National Comprehensive Cancer Network has updated its colon cancer guidelines to acknowledge recent updates to the label of the chemotherapy Xeloda (capecitabine) with a DPYD testing ...